DUBLIN, March 20, 2013 /PRNewswire/ --

Research and Markets has announced the addition of the "Personalized Medicine: Companies, Trends and World Market" report to their offering.

This broad, high-level report analyzes the expanding Personalized Medicine market. This world market includes important core medical product areas that will continue to have a powerful impact on current and future healthcare delivery. This business report examines key market segments such as targeted drugs and key personalized medicine diagnostics, including companion diagnostic IVDs, LDTs, diagnostic services and related tools or technologies.

(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

Many people already know about DNA, genes and the human genome. The science driving personalized medicine includes pharmacogenetics, pharmacoproteomics and pharmacometabalomix. Personalized medicine uses a targeted drug that depends on the patient information identified by a companion diagnostic (genetic biomarker test). The companion diagnostic identifies which patients would likely benefit from a particular therapy or those who might suffer from a bad side effect. The test information enables doctors to select the drug therapy that would benefit the patient. Drug developers in clinical trials could use a companion diagnostic to select patents that would benefit from a targeted drug.

The report discusses important technologies, including microarray, next-generation sequencing, PCR, bioinformatics, nanotechnology and other platforms. This section highlights key platforms and selected vendors. For example, the field of clinical next generation sequencing is expected to have an impact on personalized medicine.

The report covers subjects including important personalized medicine concepts. The study discusses key biomarkers, commercial diagnostics and therapeutics that drive personalized medicine. The study highlights new personalized diagnostics. This research examines the current targeted therapeutics on the market and drugs in the clinical pipeline.

The report highlights major government regulatory activities that involve personalized medicine in the US and Europe. The US FDA and the European EMA have drafted guidance papers to help drug makers and diagnostic firms develop future targeted therapies guided by companion diagnostics. The recent FDA approvals of Pfizer's Xalkori for lung cancer and Roche's Zelboraf for melanoma demonstrate that a surge in new targeted drugs is happening.

This report is in an interactive PDF format. The interactive feature uses hyperlinks that enable the reader to click the mouse to jump from Table of Contents items to sections inside the report. The hyperlinks also allow the reader to click on links to Internet information.

This study discusses important personalized medicine topics and provides the reader with key findings. The report estimates that the world personalized medicine market value will reach multi-billions of dollars in 2012, with a strong double-digit growth rate. This study reviews the activities of 31 companies.

Read more from the original source:

Personalized Medicine : Companies, Trends and World Market

Your doctor writes a prescription; the pharmacist fills it; you take the medication and get better. Thats how its supposed to work. But in the real world, plenty can go wrong, and it regularly does: More than 1.5 million potentially dangerous drug mistakes occur every year, according to the Institute of Medicine, the health arm of the National Academy of Sciences.

But with a little vigilance, you can make sure your medication leaves you healthier, not sicker. Here is a capsule review of the most common medication mistakes and how to properly take whats prescribed to you. (Spoonful of sugar optional.)

Combine similar-sounding names with illegible handwriting and what might you get? The wrong medicine. Some common mix-ups.

Adderall for ADHD Inderal for high blood pressure

Cafergot for migraines Carafate for ulcers

Celexa for depression Celebrex for arthritis

Doribax for kidney infections Zovirax for herpes simplex

Femhrt for menopausal symptoms Femara for breast cancer

Sarafem for PMS Serophene for infertility

Zantac for ulcers Xanax for anxiety

Read the original:

The most common prescription medicine mistakes

SAN BRUNO,Calif., March 19, 2013 /PRNewswire/ --Cord Blood Registry (CBR), the world's largest newborn stem cell bank, is fueling innovation in newborn stem cell research. As CBR prepares to release its 250th cord blood unit for medical use this month, the newborn stem cell bank announces that 71% of all its units released for use have been for emerging applications in regenerative medicine, such as brain injury, autism and type 1 diabetes. The other 29% have been for traditional transplant use, such as leukemia and sickle cell disease. This rapid increase in the use of family banked units for regenerative medicine applications is a complete reversal from the figures just six years ago, where 25% of the units released were for regenerative medicine applications and 75% for traditional transplant use. More than 50% of all cord blood units released for use in emerging regenerative therapies by family banks have been processed and stored at CBR. CBR is the only family newborn stem cell bank to have established FDA-regulated trials and is connecting client families to more potential treatments. As the industry leader in this initiative, Cord Blood Registry continues to focus on advancing the clinical applications of newborn stem cells.

(Photo: http://photos.prnewswire.com/prnh/20130319/SF78273-INFO)

(Logo: http://photos.prnewswire.com/prnh/20120216/AQ54476LOGO)

Over the past 20 years, cord blood stem cells have been used to treat more than 80 life-threatening diseases and disorders including certain cancers, blood disorders, immune diseases, and metabolic disorders. Today, promising treatments are paving the way for further research. Current FDA-regulated clinical trials are exploring the use of a child's own cord blood stem cells in regenerative medicine for conditions that have no cure today. Most of these groundbreaking trials only use cord blood stem cells processed and stored by Cord Blood Registry for consistency and because of their commitment to quality.

"At an increased pace, CBR is providing families exclusive access to promising new potential treatment options through our focus on clinical trials," said Geoffrey Crouse, CEO of Cord Blood Registry. "We are proud to partner with researchers at the forefront of stem cell medicine."

Clinical Trials Break New Ground in Regenerative Medicine

Cord blood stem cells are currently being evaluated in a series of clinical trials exclusive to CBR clients as potential treatment for autism, cerebral palsy, traumatic brain injury and pediatric stroke. Results will be published upon the completion of the trials.

Dr. Michael Chez, director of pediatric neurology at Sutter Medical Center, is leading a landmark FDA-regulated clinical trial to test the use of a child's own cord blood stem cells as a potential therapy to improve language and behavior in children with autism who have no obvious cause for the condition such as a known genetic syndrome or brain injury.

Dr. James Carroll at Georgia Regents University is conducting the first FDA-regulated clinical trial evaluating the use of cord blood stem cell infusions to treat children with cerebral palsy. Drake Haynes, who suffered a stroke after birth and was later diagnosed with cerebral palsy, was infused with his own CBR processed stem cells. Drake's progress is constantly being monitored and he continues to see multiple physical therapists. His family reports anecdotal evidence of steady progress in Drake's speech and mobility. Drake's mother, Nikki Haynes, describes it as the "blinds being lifted." A second FDA-regulated trial for cerebral palsy is underway at Duke University. A number of CBR families are currently participating in this key research as well.

Dr. Charles Cox, professor of pediatric surgery at The University of Texas Health Science Center in Houston (UT Health), is leading an FDA-regulated trial studying the use of a child's own cord blood stem cells in the treatment of traumatic brain injury (TBI).

Continued here:

Cord Blood Registry is Advancing Regenerative Medicine Research at Exciting Pace

INDIANAPOLIS, March 19, 2013 /PRNewswire/ --To address the leadership needs of a rapidly changing healthcare system, Indiana University Kelley School of Business in Indianapolis has launched the Business of Medicine MBA to prepare practicing physicians nationwide to assume unprecedented management roles.

The specialized two-year program will begin in September 2013, delivered as a hybrid 50 percent online, 50 percent through weekends in residence. This approach recognizes the demands on physicians' time. By combining residential and online experiences, students are assured the professional interaction central to a full MBA experience, while ensuring the program is accessible to physicians anywhere in the U.S. The new program will draw on Kelley's expertise in healthcare and life sciences, lean six sigma, consumer health behavior, supply chain, teaming and leadership. It will incorporate the longstanding and considerable experience of Kelley Direct, which was started in 1999 as the first online MBA program from a top-ranked business school.

Kelley's targeted Business of Medicine MBA recognizes the pivotal role that "physician leaders" will play in an industry grappling with historic upheaval. Challenges span the institutional spectrum, including implementing the Affordable Care Act, reducing costs while improving patient outcomes, enabling innovation under cost pressures and managing the migration of private practices into larger medical networks.

"Our Business of Medicine MBA bridges what has been the traditional divide between management and physicians on the front lines of care," said Idalene Kesner, interim dean of the Kelley School of Business. "With this degree, physician leaders will emerge with the full skillset to transform individual institutions, the broad healthcare field and, most important, patient outcomes."

Business and Management Skills that Complement Medical Knowledge

Kelley's Business of Medicine MBA was built from the ground up, pairing the essentials of business education with "reality-check" input from healthcare executives. Industry leaders cited active physician governance over business, operations and strategic direction as critical to their institutions' long-term success. Increasingly, physician executives also are navigating the shifting boundaries among research, clinical practice, industry, government and public policy.

The Business of Medicine MBA incorporates a curriculum similar to the Kelley School's full- and part-time programs (e.g., economics, operations, supply chain management, statistical analysis/analytics, strategy, marketing, organizational development, accounting, finance), with the addition of specialized courses and electives. The curriculum centers on six healthcare themes collaboration, innovation, analytics, transformation, optimization and sustainability that address new types of clinical leadership and new business models.

Even before completing this MBA, physician executives will immediately bring to their positions newly attained critical skills in healthcare and business competencies:

Full-time Faculty Noted for Cross-Industry Expertise, Experience Teaching Online

The new Business of Medicine MBA program will be taught by the Kelley School faculty, which is nationally recognized for functional expertise and experience across the healthcare continuum, including those from the school's respected Center for the Business of Life Sciences. Kelley Direct, Kelley Executive Partners the Kelley School's executive education arm and Kelley's part-time MBA program are all involved. Program participants will maximize the use of mobile technology in the learning experience. Industry executives will provide complementary lectures and cases, drawing on timely situations relatable to the physician cohort's experiences.

Link:

Kelley School of Business Launches Business of Medicine MBA

MUNICH, March 20, 2013 /PRNewswire/ --

Elsevier, a world-leading provider of scientific, technical and medical information products and services, is pleased to announce the launch of Wound Medicine-The International Wound Journal for Clinical and Health Economics Research and Applications.

Published in print and online four times a year Wound Medicine is devoted to the clinical, scientific and health economics aspects in the prevention, management and reimbursement in wound care. The journal publishes original research papers and review articles. In addition, the journal will feature standards and guidelines, commentaries, health economic analyses and selected conference papers that meet the information need of wound care specialists and service providers.

Thomas Wild and Thomas Eberlein, both from the Wound Academy in Hamburg and University Medical Center Hamburg-Eppendorf, founded the journal. Together with a prestigious international editorial team they aim to cover themes central to the journal such as: tissue repair and wound healing, diabetic foot syndrome, clinical trials and outcomes, health care and economics and service delivery. Their vision for Wound Medicine is to advance the translation of science into clinical practice and application, to improve outcomes and the patient experience.

"We are convinced that Wound Medicine will facilitate the development of standards and enhance guidelines benefitting health care professionals in and beyond Europe by putting emphasis on health improvement and economic benefits," said Thomas Wild, "The journal has been launched to provide a home for translational wound research, and we welcome submissions from all affiliated clinical fields."

"We are excited about the launch of Wound Medicine which will cover the rapidly developing area of wound care, a subject of ever increasing importance," added Helen Habernickel, Publishing Editor at Elsevier. "Our aging and diabetes prone population is at an increased risk of developing chronic wounds while normal wound healing decreases with age. This journal will provide a publication platform for the advances made in wound research."

For more information or to submit an article, go to: http://www.elsevier.com/journals/wound-medicine/2213-9095

# # #

About Elsevier Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect, Scopus, Reaxys, ClinicalKey and Mosby's Nursing Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Go here to read the rest:

Elsevier Announces the Launch of a New Journal: Wound Medicine

Bon Jovi - Bad Medicine live Because We Can Tour Columbus OH 3.10.13
Make sure to change to 1080o for full HD.

By: sportsqueenie24

See the original post:

Bon Jovi - Bad Medicine live Because We Can Tour Columbus OH 3.10.13 - Video

Bon Jovi "Bad Medicine" in Columbus
Bon Jovi performing Bad Medicine in Columbus 3-10-13 aka BEST DAY OF MY LIFE.

By: s0ftkittywarmkitty13

Follow this link:

Bon Jovi "Bad Medicine" in Columbus - Video

Bon Jovi - Bad Medicine Columbus OH 3/10/13 HD
best concert ever.

By: jbgurlx3

See the original post:

Bon Jovi - Bad Medicine Columbus OH 3/10/13 HD - Video

Dr. Ernest Yoder took time to answer questions about the new College of Medicine, its growth, focus and competition with other medical schools in Michigan.

The $30 million medical schoolwill welcome its first class of about 60 students this summer.

More than 2,700 students applied, theschool will grow from about 60 students to 100 in the next several years, and third- and fourth-year students will study in Saginaw.

CMU will have two facilities in Saginaw, one each at St. Mary's of Michigan and Covenant HealthCare Hospitals.

CMU partnered with the two Saginaw hospitals to formed a 501(c)3 corporation, Central Michigan Medical Education Partners, to manage five residency programs: emergency medicine, family medicine, internal medicine, obstetrics and gynecology, surgery and plan a sixth in psychiatry.

Central Michigan Healthcare, formerly Synergy Medical Education Alliance, will coordinate medical care in the area.

The medical school has preliminary accreditation, step three of five from the Liaison Committee on Medical Education.

What will it take to welcome the inaugural class of med students and hire 20 new faculty members?

We've done a lot of work in the last two-and-a-half years. The work can be talked about from the perspective of the institutional setting which has to do with creating culture and atmosphere of a med school, infrastructure, relationships, documentations for how to bring a medical college to life, and creating relationship within local community and within wider campus and colleges here.

The greatest work is in the education program. Were creating curriculum and instruction and assessment for students and program evaluation. Well setmeasurablegoals and objectives for students.

See the original post here:

Q&A with Central Michigan College of Medicine Dean Ernest Yoder

Private medicine might just be the solution to problems in our universal health care system. With burgeoning costs, long waiting times, doctor shortages and an aging population that will place an unprecedented burden on our public resources, private medicine offers a solution that promises to contain costs while continuing to deliver outstanding care.

Early advocates of medicare spoke of two phases. The first was to set up a universal health care system and control costs. The second more difficult phase, according to Tommy Douglas, was to "place the emphasis on preventive medicine." Financial impact studies demonstrate every dollar spent on preventive medicine returns $4 to $5 in savings. Compared with early detection or treatment, prevention also achieves superior health outcomes over the long term.

Canadian executives have known the power of preventive medicine for the last 25 years. Investments they have made in private medical programs have returned savings in terms of reduced health claims, fewer sick days, enhanced employee engagement and heightened productivity. But private clinics stand alone when it comes to programs that eliminate, delay or mitigate the impact of disease. Our system simply lacks the time, expertise and public funding.

Public funding often moves in lockstep with changes in government; prevention programs typically pay dividends over a longer period. When making hard decisions, it's often difficult to justify programs that pay back over multiple political terms. Until funding is available, GPs are unable to dedicate the necessary time - it's simply not practical to develop personalized prevention plans in a seven-to 15-minute visit.

When it comes to expertise, a sole physician cannot be expected to be a dietitian, an exercise medicine specialist, a psychologist, a case manager, a researcher, or an expert in any number of other disciplines. But private clinics often employ experts who work as part of a collaborative team providing a multitude of uninsured services in an unhurried manner. Ultimately, it's this combination of time and expertise that leads to excellent health outcomes.

Critics of private medicine often charge that elite clinics will inevitably lead to a two-tiered system. But studies done by the Canadian Institute for Health Information reveal our current system is already a combination of public and private medicine. Seventy per cent of our care is covered by public funding and 30 per cent is comprised of prescription medications, physiotherapy, specialized lab tests and other services privately funded.

Another popular myth is that all private clinics offer a fast lane for wealthy Canadians to circumvent waiting times and the Canada Health Act. This is simply not the case. Cope-man Healthcare, a private Vancouver-based clinic, was audited by the Medical Services Commission in 2007 and given a clean bill of health.

"We provide a navigation and advocacy service that is very helpful in ensuring timely and appropriate fol-lowup care," explains Don Copeman, founder of Copeman Healthcare.

The LifePlus program at Copeman Healthcare in Vancouver is a $3,200 uninsured service that integrates the care of physicians with a collaborative team of medical professionals. Executive health programs are offered at $1,400.

Rather than quibble over public versus private, why not consider a hybrid system? Highly respected European models are based on public-private partnerships that foster collaboration, sharing and cross-pollination of ideas.

Continue reading here:

Opinion: Private medicine has role to play in prevention

FIFA Chairman Sepp Blatter (left) and FIFA Medical Commission Chairman Michel D'Hooghe pose at a press conference last week.

AFP/Getty Images

BRUSSELS -- The abuse of anti-inflammatory medicine by football players is a bigger problem facing the sport than doping, FIFA medical chief Michel D'Hooghe said Monday.

D'Hooghe said the abuse of anti-inflammatories is increasingly more prominent among teenage players who counter any bruise or over-exertion of muscles with the strong medicines which can have serious effects on kidneys, stomach and intestines later in life.

"The most worrying aspect is that we see the problem moving ever more into the youth categories,'' D'Hooghe said in an interview with The Associated Press.

He said the increase among younger players was especially evident at the 2011 Under- 17 World Cup in Mexico and had risen since.

FIFA has been hit by relatively few major doping cases in its history and D'Hooghe said beyond the cost of the anti-doping testing program, the world football federation should try to center on other issues, too.

"Doping is not our biggest problem. The anti-inflammatories are our biggest problem,'' D'Hooghe said.

FIFA got its first major warning on the abuse of the non-steroidal anti-inflammatory at the 2010 World Cup in South Africa, where teams have to let FIFA know from 72 hours in advance of a game what medicine players get.

"There was one team where 21 of 23 players were using them,'' D'Hooghe said.

Read more here:

FIFA fears abusing of anti-inflammatory medicine

FIFA Chairman Sepp Blatter (left) and FIFA Medical Commission Chairman Michel D'Hooghe pose at a press conference last week.

AFP/Getty Images

BRUSSELS -- The abuse of anti-inflammatory medicine by football players is a bigger problem facing the sport than doping, FIFA medical chief Michel D'Hooghe said Monday.

D'Hooghe said the abuse of anti-inflammatories is increasingly more prominent among teenage players who counter any bruise or over-exertion of muscles with the strong medicines which can have serious effects on kidneys, stomach and intestines later in life.

"The most worrying aspect is that we see the problem moving ever more into the youth categories,'' D'Hooghe said in an interview with The Associated Press.

He said the increase among younger players was especially evident at the 2011 Under- 17 World Cup in Mexico and had risen since.

FIFA has been hit by relatively few major doping cases in its history and D'Hooghe said beyond the cost of the anti-doping testing program, the world football federation should try to center on other issues, too.

"Doping is not our biggest problem. The anti-inflammatories are our biggest problem,'' D'Hooghe said.

FIFA got its first major warning on the abuse of the non-steroidal anti-inflammatory at the 2010 World Cup in South Africa, where teams have to let FIFA know from 72 hours in advance of a game what medicine players get.

"There was one team where 21 of 23 players were using them,'' D'Hooghe said.

Read more:

FIFA fears abuse of anti-inflammatory medicine

Nampally Court wants to know secret of Bathini Fish medicine:11/03/13 - Studio N
http://www.studiononline.com http://twitter.com/StudioNonline http://www.youtube.com/studiononline http://www.youtube.com/studionchannel http://www.facebook....

By: studionchannel

View post:

Nampally Court wants to know secret of Bathini Fish medicine:11/03/13 - Studio N - Video

Bon Jovi 2013 - Bad Medicine
Because We Can Tour - Columbus, Ohio - March 10, 2013 Not the greatest picture quality, but it was an awesome show!!

By: Michelle Reichenbach

Read more from the original source:

Bon Jovi 2013 - Bad Medicine - Video

Heparin is an anticoagulant and the prescription version is made from pig, raising concerns for vegans.

Heparin is an anticoagulant and the prescription version is made from pig, raising concerns for vegans.

Go looking for animal products, and apparently you will find them everywhere.

That's the takeaway from the book Veganissimo A to Z, recently translated into English for the first time. What's veganissimo? It's veganism of the highest order, according to the German authors Reuben Proctor and Lars Thomsen, who call themselves "professional vegans." (Is veganism a healthful way to eat? Sorry, we're not going there in this post.)

Proctor and Thomsen, who've been vegan since 2000 and 1990, respectively, are willing to avoid animal products on ethical grounds at nearly all costs. And a perusal of their guide to more than 2,500 substances is enough to give even a non-vegan a bout of vicarious anxiety the byproducts of dead animals, it seems, are lurking in everything from diet supplements and medicine to sporting goods and electronics.

When it comes to pharmaceuticals, the authors say, there's a surprising amount of animal in many of those pills in your medicine cabinet. And that can present vegans with serious quandaries, pitting their health against their ideals.

"Medicine is one of the more difficult products for vegans to avoid, especially if something is life-threatening," Proctor tells Shots. "How far are you prepared to go for your own convictions?"

The most common animal derivative in the medicine cabinet is lactose, which is used as a carrier, stabilizer or to add bulk. And if you want to get technical about it (and Proctor's book certainly does), you'll learn that gelatin (derived from the skin and bone of cattle and pigs) shows up in many capsules, pills and tablets.

Your pills might also be bound with insect-based shellac or magnesium stearate, a substance based on fatty acids that can come from animals. And if pills have a pinkish or reddish tint, it could be from cochineal, or carmine, a red dye made from crushed insects. (Recall, if you will, that brouhaha over Starbucks' use of the dye to color its Strawberry and Crme Frappucinos.)

According to Proctor, vegans also have to worry about active ingredients in other drugs like insulin, anticoagulents like heparin, amino acid infusions, and hormone preparations.

See the rest here:

Is Your Medicine Vegan? Probably Not

Go natural... go herbal... go organic. This is now the battlecry of many people of different cultures; of different races; of different ages; of different lifestyle; and of different professions.

Simply, herbal products in its strict sense are those products that are prepared from plants without using additives, preservatives, artificial colors and flavors.

Herbal products can be classified into herbal medicine, personal care and herbal cosmetics and herbal foods.

Herbal medicine (sometimes referred to as herbalism or botanical medicine) is the use of herb plant or plant parts for the treatment or prevention of diseases, disorders and the promotion of good health.

Here are some interesting and revealing trivia about herbal medicine:-

Do you know that herbal medicine has a long and respected history? In fact, herbal medicine is the oldest form of health care known to mankind;

Do you know that many drugs commonly used today are of herbal origin;

Do you know that herbal healing has been passed from generation to generation by word of mouth? Although for the past many years, subjects on herbalism are now being offered in some educational institutions;

Do you know that to date, the World Health Organization (WHO) estimates that 4 billion people (80% of world population) use herbal medicine in one form or another;

Do you know that there are over 750,000 plants on earth? It is saddening to note that to date very few of the healing herbs have been studied scientifically;

Read the original post:

Herbal Medicine

POMONA, CA--(Marketwire - Mar 15, 2013) - Western University of Health Sciences College of Dental Medicine will receive $8.4 million from First 5 LA to provide dental care to uninsured and underserved children.

The First 5 LA Commission approved the initial 19-month contract for $3.1 million with WesternU, part of a five-year, $38 million project in cooperation with UCLA and USC. The total awarded to WesternU through the full five-year implementation of the program is anticipated to be $8.4 million.

The program will emphasize getting children into the oral health care delivery system, or dental homes, by age 1, said Timothy Martinez, DMD, College of Dental Medicine Associate Dean for Community Partnerships and Access to Care.

College of Dental Medicine faculty and students will assess patients and provide dental care and preventative and educational services. The College will work with the San Gabriel Valley Foundation for Dental Health, WesternU's Patient Care Center, and the Center for Oral Health, which is now housed on WesternU's Pomona campus. It also plans to work collaboratively to establish four school-based dental oral health centers.

"We want to track the patients, make sure they're getting into dental care, make sure their treatment plans are being completed, and make sure they're put on preventative maintenance," Martinez said. "That's how you take care of a population and keep them healthy."

WesternU is working with school districts that have high Medicaid enrollment, and one goal is to create sustainability.

"We're trying to integrate oral health services with established school-based health centers, and we're going to develop processes to help support those programs," Martinez said. "The goal is to demonstrate how dentists can be successful providing services at these schools. We also have interprofessional training, teaching nurse practitioners and physician assistants about anticipatory guidance, which is how to prevent caries (cavities), talking to mothers, and how to apply fluoride varnish."

This program will introduce College of Dental Medicine students to caring for very young patients early in their education, which does not typically happen in dental schools, said College of Dental Medicine Dean Steven W. Friedrichsen, DDS.

"While providing essential dental services, the project will also help prepare the next generation of dentists to understand the importance of a dental home, a first dental visit by their first birthday, and early intervention and treatment for these children," he said.

First 5 LA is a unique child-advocacy organization created by California voters to invest tobacco tax revenues in programs aimed at improving the lives of children in Los Angeles County, from prenatal through age 5.

Go here to see the original:

WesternU's College of Dental Medicine to Receive $8.4 Million From First 5 LA

Public release date: 15-Mar-2013 [ | E-mail | Share ]

Contact: Steve Majewski 215-351-2514 American College of Physicians

PHILADELPHIA, March 15, 2013 -- The number of U.S. senior medical students choosing categorical internal medicine residencies increased for the fourth consecutive year. According to the 2013 National Resident Matching Program, 3,135 U.S. medical school seniors matched for residency training in internal medicine, a 6.6 percent increase compared to 2012, when 2,941 matched in internal medicine.

The report also showed a continued increase of U.S. medical graduates who matched in Internal Medicine-Primary Care (200 in 2013, 186 in 2012, and 166 in 2011) and in Med-Peds (increased to 312 in 2013, up from 276 in 2012).

"We are pleased that more U.S. medical students are choosing internal medicine residencies and hope the upward trend continues," said Steven Weinberger, MD, FACP, executive vice president and CEO, American College of Physicians (ACP), the nation's largest medical specialty organization. "However, ACP remains concerned about the need to increase the nation's general internal medicine physician workforce to meet the needs of an aging population requiring care for chronic and complex illnesses and the increased number of individuals who will be receiving coverage through the Affordable Care Act."

The 2013 match for internal medicine is still well below the 3,884 U.S. medical school graduates that chose internal medicine residency programs in 1985.

Categorical internal medicine enrollment numbers decreased from 2007 to 2009 (2,680 in 2007; 2,660 in 2008; and 2,632 in 2009) before increasing in 2010 (2,772) and 2011 (2,940). The great majority of current internal medicine residents will ultimately enter a subspecialty of internal medicine, such as cardiology or gastroenterology. Only about 20 to 25 percent of internal medicine residents eventually choose to specialize in general internal medicine, compared with 54 percent in 1998.

Dr. Weinberger also cited problematic payment models and the exorbitant cost of medical education with the resulting financial burden on medical students and residents as barriers to a career in general internal medicine.

###

About the American College of Physicians

Here is the original post:

Internal Medicine residency match results encouraging for adults needing primary care

Daughter - Medicine (Sound Remedy Remix)
Phenomenal remix! Sound Remedy http://soundcloud.com/soundremedy http://www.soundremedy.com/ http://www.facebook.com/soundremedy https://twitter.com/SoundRem...

By: MrSuicideSheep

Follow this link:

Daughter - Medicine (Sound Remedy Remix) - Video

Scientific Approach of Korean Medicine: Min Ho Nam at TEDxUNIST
In the spirit of ideas worth spreading, TEDx is a program of local, self-organized events that bring people together to share a TED-like experience. At a TED...

By: TEDxTalks

View post:

Scientific Approach of Korean Medicine: Min Ho Nam at TEDxUNIST - Video